Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;35(9):e15732.
doi: 10.1111/dth.15732. Epub 2022 Aug 2.

Magnesium microneedle patches for under-eye wrinkles

Affiliations

Magnesium microneedle patches for under-eye wrinkles

Donghwi Jang et al. Dermatol Ther. 2022 Sep.

Abstract

Microneedling is a common cosmetic procedure for improvement of wrinkles, acne, scars, and other conditions. Various microneedle (MN) patches have been developed as home care therapy for wrinkles and skin texture. Most of them are made of soluble and absorbable needles. To evaluate the efficacy and safety of non-absorbable magnesium (Mg) MN patches on under-eye wrinkles. A total of 20 subjects aged 27-58 years was enrolled in the study. The subjects applied Mg MN patches on the under-eye wrinkle area for 1-2 h every other night for 12 weeks. The evaluation comprised grading by clinicians, measuring the wrinkle index with a facial analyzer, and measuring the dermal thickness of the under-eye area with ultrasonography. Any adverse events and discomfort were addressed during the study. The application of Mg MN patches on under-eye areas showed improvements in under-eye grading scale, wrinkle index, and dermal thickness after 12 weeks. The mean grading scale significantly improved after 8 weeks of application (p < 0.01). The wrinkle index showed significant improvement after 12 weeks on the right under-eye area (p < 0.05). The dermal thickness of the under-eye area tended to increase, but no statistically significant changes were observed. Non-absorbable Mg MN patches can be used for under-eye wrinkles with minimal discomfort.

Keywords: efficacy; magnesium; microneedle patch; safety; under-eye wrinkles.

PubMed Disclaimer

Conflict of interest statement

We have no conflict of interest except national funding by the Ministry of Trade, Industry, & Energy (MOTIE, Korea).

Figures

FIGURE 1
FIGURE 1
(A) An image of a microneedle patch. (B) The patch application on the under‐eye area. The locations of the measurement site of the dermal thickness using ultrasonography are shown (indicated by black arrow, 2 cm below the lateral canthus of both eyes)
FIGURE 2
FIGURE 2
The grading scale of under‐eye wrinkles was developed for the evaluation of under‐eye wrinkles. Grade 1 (GR 1): a few distinct, fine wrinkles; Grade 1.5 (GR 1.5): a few distinct, fine wrinkles with one or two moderate wrinkles; Grade 2 (GR 2): numerous distinct, fine wrinkles with a deep wrinkle confined to the medial side; Grade 2.5 (GR 2.5): numerous distinct, fine wrinkles with a few moderate wrinkles; Grade 3 (GR 3): numerous distinct, fine wrinkles with a deep wrinkle on both medial and lateral sides and/or indistinct bag under eyes; Grade 3.5 (GR 3.5): numerous distinct, fine wrinkles with three or four deep wrinkles and/or distinct bags under eyes. Grade 0 (no wrinkles) and Grade 4 (numerous distinct, fine, and moderate wrinkles with numerous deep wrinkles) are not shown in the picture
FIGURE 3
FIGURE 3
Photographs of a representative subject with under‐eye wrinkles showing clinically favorable improvement. (A) Frontal view at V1 (week 0) and at week V5 (week 12), (B) right oblique view at V1 and V5, and (C) left oblique view at V1 and V5
FIGURE 4
FIGURE 4
The mean grading scale of under‐eye wrinkles from week 0 (V1) to week 12 (V5) after application of MN patch. **p < 0.01, statistically significant compared with week 0
FIGURE 5
FIGURE 5
The mean change of wrinkle index by facial analyzer (Mark‐Vu®) (A) right and (B) left under‐eye area from week 0 (V1) to week 12 (V5). *p < 0.05, statistically significant compared with week 0
FIGURE 6
FIGURE 6
The ultrasound images of the representative subjects at V1 (week 0) and V5 (week 12)
FIGURE 7
FIGURE 7
The comparison of mean dermal thickness of the right and left under‐eye areas at week 0 (V1) and week 12 (V5)

References

    1. He X, Sun J, Zhuang J, Xu H, Liu Y, Wu D. Microneedle system for transdermal drug and vaccine delivery: devices, safety, and prospects. Dose Response. 2019;17:1559325819878585. - PMC - PubMed
    1. McCrudden MT, McAlister E, Courtenay AJ, Gonzalez‐Vazquez P, Singh TR, Donnelly RF. Microneedle applications in improving skin appearance. Exp Dermatol. 2015;24:561‐566. - PubMed
    1. Nguyen TT, Park JH. Human studies with microneedles for evaluation of their efficacy and safety. Expert Opin Drug Deliv. 2018;15:235‐245. - PubMed
    1. Singh A, Yadav S. Microneedling: advances and widening horizons. Indian Dermatol Online J. 2016;7:244‐254. - PMC - PubMed
    1. Waghule T, Singhvi G, Dubey SK, et al. Microneedles: a smart approach and increasing potential for transdermal drug delivery system. Biomed Pharmacother. 2019;109:1249‐1258. - PubMed